The University of Chicago Header Logo

Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias.

Changing lanes: extending CAR T-cell therapy to high-risk plasma cell dyscrasias. Front Immunol. 2025; 16:1558275.

View in: PubMed